1.
Simpson E, Blauvelt A, Guttman-Yassky E, Worm M, Lynde C, Saeki H, Poulin Y, Wollenberg A. Efficacy and Safety of Tralokinumab Monotherapy in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Results from Two 52-Week, Phase 3 Trials (ECZTRA 1 and ECZTRA 2). J of Skin [Internet]. 2020Oct.27 [cited 2021Jan.25];4(6):s96. Available from: https://jofskin.org/index.php/skin/article/view/1066